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A B S T R A C T   
Functional neurological disorder (FND) was of great interest to early clinical neuroscience leaders. During the 
20th century, neurology and psychiatry grew apart – leaving FND a borderland condition. Fortunately, a re-
naissance has occurred in the last two decades, fostered by increased recognition that FND is prevalent and 
diagnosed using “rule-in” examination signs. The parallel use of scientific tools to bridge brain structure - 
function relationships has helped refine an integrated biopsychosocial framework through which to conceptu-
alize FND. In particular, a growing number of quality neuroimaging studies using a variety of methodologies 
have shed light on the emerging pathophysiology of FND. This renewed scientific interest has occurred in parallel 
with enhanced interdisciplinary collaborations, as illustrated by new care models combining psychological and 
physical therapies and the creation of a new multidisciplinary FND society supporting knowledge dissemination 
in the field. Within this context, this article summarizes the output of the first International FND Neuroimaging 
Workgroup meeting, held virtually, on June 17th, 2020 to appraise the state of neuroimaging research in the 
field and to catalyze large-scale collaborations. We first briefly summarize neural circuit models of FND, and then 
detail the research approaches used to date in FND within core content areas: cohort characterization; control 
group considerations; task-based functional neuroimaging; resting-state networks; structural neuroimaging; 
biomarkers of symptom severity and risk of illness; and predictors of treatment response and prognosis. Lastly, 
we outline a neuroimaging-focused research agenda to elucidate the pathophysiology of FND and aid the 
development of novel biologically and psychologically-informed treatments.   
1. Introduction 
Functional neurological disorder (FND), also known as conversion 
disorder and previously termed hysteria, is a prevalent and disabling 
condition at the interface of neurology and psychiatry (Espay et al., 
2018a; Perez et al., 2021). FND was of great interest to early clinical 
neuroscience leaders, with Jean-Martin Charcot stating “the neurolog-
ical tree has its branches, neurasthenia, hysteria, epilepsy, all the types 
of mental conditions, progressive paralysis, (and) gait ataxia” (Charcot, 
1887). Despite Charcot’s integrated perspective and forward-thinking 
“dynamic or functional lesion” theory for FND (Charcot, 1889), limita-
tions in available neuroscientific tools at the time contributed to a 
singular focus on psychological conceptualizations as originally posited 
by Sigmund Freud and Pierre Janet (Breuer and Freud, 1895; Janet, 
1907). The divide between neurology and psychiatry expanded in the 
20th century, leaving FND as a borderland condition (Fend et al., 2020). 
Notably, this “crisis” was met with calls for action (Edwards, 2019; 
Hallett, 2006; Keynejad et al., 2017; LaFrance and Devinsky, 2004; 
Nicholson et al., 2011). 
A renaissance has occurred in the last two decades, catalyzed by 
emphasis on “rule-in” physical signs guiding diagnosis (Stone et al., 
2010b), a growing repertoire of evidence-based treatments, establish-
ment of a multidisciplinary FND Society (www.fndsociety.org), and the 
publication of authoritative textbooks (Hallett et al., 2016; Kozlowska 
et al., 2020). This renewed interest parallels recognition that FND is the 
2nd most common outpatient neurologic diagnosis, with many patients 
remaining chronically symptomatic and incurring high healthcare costs 
(Gelauff et al., 2019; Stephen et al., 2021; Stone et al., 2010a). Informed 
by the biopsychosocial model, this sets the stage for advancing the 
pathophysiology of FND using multimodal neuroimaging (Baizabal- 
Carvallo et al., 2019; Bègue et al., 2019; Pick et al., 2019; Voon et al., 
2016). Elucidating the neurocognitive mechanisms of FND will aid the 
identification of biomarkers guiding treatment selection and prognosis, 
help patients better understand their condition, decrease stigma, and 
promote the development of biologically and psychologically-informed 
treatments. 
Compared to brain imaging in other neuropsychiatric disorders, FND 
research remains in its early stages (e.g., no samples > 100 patients, few 
findings replicated, and even fewer studies tied to treatments). In 
addition to being understudied, several inherent challenges are impor-
tant considerations. Firstly, patients with FND can present with a wide 
range of neurological symptoms in isolation or in combination; addi-
tionally, individuals can develop different functional neurological 
symptoms over the natural history of their illness (McKenzie et al., 2011; 
Nicholson et al., 2020). Secondly, patients with FND have high rates of 
other physical (e.g., pain, fatigue) and psychiatric symptoms (e.g., 
anxiety, depression) (Goldstein et al., 2020; Kranick et al., 2011; Nich-
olson et al., 2020; Stone et al., 2010c). However, there is significant 
variability across patients. Thirdly, evidence suggests that FND has 
various etiologic contributors, including roles for adverse life experi-
ences and acute/chronic physical and psychological stressors (Ludwig 
et al., 2018). However, risk factors vary across patients - highlighting 
roles for individual differences, developmental trajectories, 
stress-diathesis models, and gene by environment interactions 
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(Apazoglou et al., 2018; Diez et al., 2020; Keynejad et al., 2019; Spag-
nolo et al., 2020; Voon et al., 2016). Finally, some brain areas in the 
neurocircuitry of FND may be at the intersection of negative affect, 
nociception, cognitive control, beliefs/expectations, self/emotional 
awareness, and developmental factors (Cretton et al., 2020; Deeley, 
2016; Edwards et al., 2012; Shackman et al., 2011). 
Within this context, an inaugural International FND Neuroimaging 
Workgroup meeting (led by D.L.P., T.R.N., S.A.) was held virtually on 
June 17th, 2020 to bring together FND neuroimaging researchers and 
thought leaders to catalyze research and collaboration in the field. This 
perspective article details themes discussed at the meeting. Here, we 
first succinctly review neural circuit models of FND based on the func-
tional and structural neuroimaging literature. Then, we discuss the state 
of brain imaging research in FND emphasizing methodological consid-
erations within core content areas: cohort characterization; control 
group considerations; functional neuroimaging tasks; intrinsic func-
tional and structural brain architecture; biomarkers of symptom severity 
and risk of illness; and predictors and neural mechanisms of treatment 
response and prognosis. Lastly, we propose a neuroimaging-focused 
research agenda for FND to help promote high impact advances in un-
derstanding neural mechanisms and aid the development of biologically 
and psychologically-informed treatments. 
2. FND Neural Circuitry - A Synopsis 
Across functional and structural neuroimaging studies, evidence 
supports modeling FND as a multi-network brain disorder implicating 
alterations within and across limbic/salience, self-agency/multimodal 
integration, attentional, and sensorimotor circuits (Baizabal-Carvallo 
et al., 2019; Bègue et al., 2019; Drane et al., 2020; Foroughi et al., 2020; 
Szaflarski and LaFrance, 2018; Voon et al., 2016). Studies where pa-
tients engage in affectively-valenced tasks while being scanned have 
generally characterized increased limbic/paralimbic activity in patients 
with FND compared to controls (Pick et al., 2019). For example, 
impaired amygdala habituation and increased sensitization has been 
described in patients with functional motor symptoms compared to 
controls, along with increased functional connectivity between the 
amygdala and motor control circuits (Aybek et al., 2015, 2014b; Espay 
et al., 2018c; Hassa et al., 2017; Morris et al., 2017; Voon et al., 2010a). 
However, findings have been inconsistent, including reports of normal 
or hypoactive amygdala responses in functional movement disorder 
(FND-movt) and functional [psychogenic nonepileptic / dissociative] 
seizure (FND-seiz) cohorts, respectively (Allendorfer et al., 2019; Bala-
chandran et al., 2020; Espay et al., 2018c). Across emotion processing 
and motor control tasks, altered insula, cingulate gyrus, and ventro-
medial prefrontal cortex activations have also been described (Aybek 
et al., 2015; Cojan et al., 2009; Espay et al., 2018b; Stone et al., 2007; 
Voon et al., 2011). These findings, particularly heightened amygdala- 
motor control circuit coupling, may represent markers of heightened 
limbic influence over motor behavior (Voon et al., 2010a). Preliminary 
data also suggest that baseline increased task-related corticolimbic ac-
tivity may predict treatment responses to cognitive behavioral therapy 
(CBT) and short-term inpatient multidisciplinary motor retraining 
(Espay et al., 2019; Faul et al., 2020). 
Task neuroimaging in FND-movt has also identified an important 
role for the right temporoparietal junction (rTPJ) based network in self- 
agency disturbances (Baizabal-Carvallo et al., 2019; Zito et al., 2020). 
For example, a within-group study comparing functional (involuntarily 
perceived) movements to volitional movements in a functional tremor 
cohort showed hypoactivation of the rTPJ (Voon et al., 2010b). This 
study also identified reduced connectivity between primary sensori-
motor regions and the rTPJ, suggesting impaired feed forward pro-
cessing. Other studies across a variety of FND subtypes support roles for 
brain circuits implicated in motor conceptualization, inhibitory control, 
attention, predictive processing/perceptual inference, meta-cognition, 
belief/expectation, emotion control, and threat-related defense 
behaviors in the pathophysiology of FND (Allendorfer et al., 2019; 
Aybek et al., 2015; Balachandran et al., 2020; Bègue et al., 2018; Deeley 
et al., 2013; Edwards et al., 2012; Espay et al., 2018b; Schrag et al., 
2013; Voon et al., 2016). 
Resting-state functional connectivity and quantitative structural 
imaging approaches have been used to investigate intrinsic brain ar-
chitecture in FND. In resting-state functional connectivity magnetic 
resonance imaging (rsfcMRI) studies, FND-movt and FND-seiz cohorts 
have shown aberrant (generally increased) connectivity between 
emotion processing (cingulo-insular, amygdala) and motor control 
networks (Diez et al., 2019; Morris et al., 2017; van der Kruijs et al., 
2012; Wegrzyk et al., 2018) compared to healthy controls; increased 
cingulo-insular coupling to motor control areas correlated with symp-
tom severity in several studies (Diez et al., 2019; Li et al., 2015a, 2015b). 
Decreased resting-state functional connectivity between the rTPJ and 
primary sensorimotor regions in FND-movt compared to healthy con-
trols has also been reported (Maurer et al., 2016); similarly, hypo-
metabolism of the right inferior parietal lobule and dorsal anterior 
cingulate on positron emission tomography (PET) has been character-
ized in patients with FND-seiz (Arthuis et al., 2015). Nonetheless, only a 
small subset of studies combined resting-state and task-based fMRI data 
(Baek et al., 2017; Morris et al., 2017; Szaflarski et al., 2018), suggesting 
that the specific involvement of discrete brain networks in FND pop-
ulations remains incompletely understood. As detailed in a recent sys-
tematic review (Bègue et al., 2019), grey matter alterations in 
sensorimotor, cingulo-insular and amygdala brain areas have been 
identified, although findings have been inconsistent (Aybek et al., 
2014a; Espay et al., 2018c; Labate et al., 2012; Maurer et al., 2018; 
Nicholson et al., 2014; Tomic et al., 2018). The importance of individual 
differences and possible subgroup specific effects in understanding the 
pathophysiology of FND have also been demonstrated (e.g., Perez et al., 
2017b showed that reduced left anterior insula volume was only present 
in those patients reporting the most severe physical health impairments 
compared to healthy controls) (Aybek et al., 2014a; Canu et al., 2020; 
Labate et al., 2012; Maurer et al., 2016, 2018, Perez et al., 2018b,a; 
Tomic et al., 2018). White matter characterization in FND is in its early 
stages, with initial findings pointing towards altered limbic and asso-
ciative fiber bundles compared to healthy (Diez et al., 2021; Hernando 
et al., 2015; Lee et al., 2015; Sojka et al., 2021; Tomic et al., 2018) and 
traumatic brain injury controls (Goodman et al., 2020). Developmental 
trajectories in pediatric FND – including the transition from adolescence 
to adulthood – and neurochemical (magnetic resonance spectroscopy 
(MRS)) studies remain markedly under-investigated (Demartini et al., 
2019; Kozlowska et al., 2017a). A few imaging studies have examined 
the intersection of neural mechanisms and etiological (risk) factors, 
focusing primarily on associations between childhood maltreatment and 
experience-dependent neuroplasticity (Diez et al., 2020; Maurer et al., 
2016, 2018; Perez et al., 2017a; Spagnolo et al., 2020). Pilot studies 
provide initial evidence that baseline intrinsic functional and structural 
profiles in FND relate to 6-month clinical outcomes (Diez et al., 2019; 
Perez et al., 2018b). For more details on the pathophysiology of FND, see 
several recent reviews (Baizabal-Carvallo et al., 2019; Bègue et al., 
2019; Drane et al., 2020; McSweeney et al., 2017; Voon et al., 2016). 
3. FND Characterization Considerations 
Given phenotypic heterogeneity, interpretation of FND-related neu-
roimaging findings depends a great deal on rigorous cohort character-
ization (Gelauff et al., 2020; Matin et al., 2017; McKenzie et al., 2011). 
Additionally, FND presents diagnostic challenges that likely impact 
neuroimaging research. These reflect, in part, the somewhat underde-
veloped diagnostic criteria for “Conversion Disorder (Functional 
Neurological Symptom Disorder)” found in the Diagnostic and Statisti-
cal Manual of Mental Disorders–Fifth Edition (DSM-5) and International 
Classification of Diseases–11th Revision (ICD-11) (Stone et al., 2014). In 
DSM-5, a patient can be diagnosed with FND if they have motor and/or 
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sensory findings providing “evidence of incompatibility between the 
symptom and recognized neurological or medical conditions” (American 
Psychiatric Association, 2013; Stone et al., 2010b). The symptom must 
impair social and/or occupational functioning or lead individuals to 
seek a medical opinion. There are no duration or severity criteria or 
explicit rules for exclusion based on additional symptoms. In the 
neurological literature, there are also diagnostic criteria for FND sub-
types, such as those for FND-seiz (LaFrance et al., 2013a) and FND-movt 
(Espay and Lang, 2015; Gasca-Salas and Lang, 2016; Williams et al., 
1995). Unsurprisingly, varying FND diagnostic criteria have been used 
across studies. Despite this heterogeneity, a general emphasis on “rule- 
in” examination signs and semiological features guiding diagnosis has 
been used, including the ‘gold-standard’ adjunctive video- 
electroencephalography (vEEG) for FND-seiz (LaFrance et al., 2013a). 
Despite these potential concerns with the current criteria, FND di-
agnoses are reliable over time - misdiagnosis is rare in published studies 
(Stone et al., 2005). The same cohort studies in adults also show 
symptom persistence in the majority, indicating that we are generally 
not dealing with transient symptoms, at least in research populations 
where participants have usually been ill for months to years before in-
clusion (Gelauff and Stone, 2016). 
Based on phenotypic complexity, FND neuroimaging researchers 
need to consider how the following factors could lead to heterogeneity:  
a. Symptom severity: For example, we likely want to differentially 
consider a patient with a heavy leg that drags occasionally and 
someone with quadriplegia.  
b. Episodic vs. persistent: Whilst some symptoms are episodic such as 
seizures, others may vary. Patients may at times have only inter-
mittent limb weakness, and at other instances a more static paralysis.  
c. Duration and Onset: It is likely that someone who has had functional 
paraplegia for 20 years would have different neuroimaging corre-
lates compared to an individual with symptoms for a month 
(including compensatory neuroplasticity changes from underuse) 
(Newbold et al., 2020). Illness duration may be especially important 
in connectivity and structural neuroimaging studies. Additionally, 
FND neural mechanisms in children/adolescents, adults and late-life 
presentations require inquiry regarding to what extent mechanisms 
are shared across the lifespan.  
d. Symptom type and overlap: Many patients with FND have overlapping 
symptoms. For example, some with functional tremor or dystonia 
will also exhibit functional weakness or sensory deficits in the same 
limb and/or have current or past FND-seiz (Gelauff et al., 2020; 
Matin et al., 2017).  
e. Symptom location: It may be important for some studies to explicitly 
define symptom location, for example, face, arm or leg, and the 
laterality. 
Additional physical and mental health diagnoses in FND, at least as 
currently defined, are the norm rather than an exception (Nicholson 
et al., 2020). Pain, fatigue, insomnia, and cognitive symptoms are 
generally found in more patients with FND than not. Other functional 
somatic disorders such as functional bowel, bladder and cardiorespira-
tory symptoms are also common. Psychiatric conditions, especially af-
fective, trauma-related and/or dissociative disorders, are typically 
present in over 50% of most FND samples, with lifetime rates even 
higher (Bowman and Markand, 1996; Goldstein et al., 2020; Gray et al., 
2020; Kozlowska et al., 2011; Kranick et al., 2011; Sar et al., 2004; Stone 
et al., 2010c). Personality disorders also exist in patients with FND at 
higher frequencies than that in the general population, with personality 
traits such as neuroticism, obsessiveness and/or emotional dysregula-
tion commonly recognized (Ekanayake et al., 2017; Szaflarski et al., 
2015). Adverse life events, a predisposing vulnerability for FND, are 
frequently reported though not universally so (Ludwig et al., 2018). 
Additionally, other neurological conditions may be present, such as 
patients with both FND-seiz and epileptic seizures, or individuals with 
Parkinson’s disease and motor FND (Kutlubaev et al., 2018; Wissel et al., 
2018); the intersection of mild traumatic brain injury and FND-seiz is 
also well recognized (LaFrance et al., 2013b; Popkirov et al., 2018). 
Psychotropic medications are frequently prescribed in patients with 
FND to manage anxiety, depression, pain, fatigue, and insomnia, among 
other symptoms. In FND, neuroimaging studies have varied in their 
characterization of other concurrently present medical/neurological 
and psychiatric conditions; for example, only a subset of studies per-
formed structured psychiatric interviews. Additionally, only a few 
studies have attempted to adjust for psychiatric symptoms and medi-
cation effects in their analyses. Relatedly, serotonergic-based medica-
tions modulate emotion processing circuits (particularly the amygdala), 
and efforts to adjust for medication use may help reconcile differences in 
findings across studies (Godlewska et al., 2012). 
How is the neuroimaging researcher to deal with this complexity and 
potential confounding? Control group considerations discussed below 
are one approach. Studying FND severity using within-group designs 
may also be helpful but complex, as studies show that symptom severity 
and affective symptoms can co-vary (Rawlings et al., 2017). Addition-
ally, there are difficulties in knowing whether to attempt objective 
measurements or to rely entirely on patient reports. A recent interna-
tional collaboration on FND outcome measures concluded that measures 
based on subjective reports were probably more meaningful, especially 
when considering that symptoms like functional leg weakness, by defi-
nition, can often be demonstrated temporarily to be absent (Nicholson 
et al., 2020; Pick et al., 2020). Similarly, regarding risk factors, sub-
jective reports of high childhood maltreatment burden are strong pre-
dictors of later-life psychopathology - irrespective of objective 
documentation (Danese and Widom, 2020). Although large samples are 
required to avoid type 2 errors, another solution includes using statis-
tical adjustments for possible confounding factors in secondary analyses 
(e.g., performing analyses and reporting findings adjusting and not 
adjusting for variables such as depression scores). A more radical 
perspective is to reframe some of the diagnostic and comorbidity chal-
lenges by adopting a position that FND, in its naturally presenting state, 
is not a pure disorder, and its ‘comorbidities’ are intrinsic to its patho-
physiology. Those seeking to study FND should therefore potentially not 
regard prevalent ‘comorbidities’ as noise / nuisance factors, but part of 
the condition to be understood. 
4. Control Group Considerations 
The choice of controls is a key design element for FND studies. In 
FND, the majority of studies to date have used healthy controls or 
within-subject designs (Allendorfer et al., 2019; Bègue et al., 2019; 
McSweeney et al., 2017; Voon et al., 2016). Using healthy controls has 
benefits, including that between-group findings can be established to be 
outside the normal range; however, covarying affective symptoms and 
psychotropic medication use in the FND cohort limit the ability to relate 
observations as definitively associated with FND itself. 
Another option is to use patient controls with comparable non-FND 
symptoms to those found in the FND cohort. Only a few studies have 
used neurological or psychiatric controls in FND research to date, 
including primary dystonia (Espay et al., 2018b; Schrag et al., 2013), 
essential tremor (Espay et al., 2018c), traumatic brain injury (Bala-
chandran et al., 2020; Goodman et al., 2020) and a mixed depressio-
n/anxiety psychiatric control group (Diez et al., 2020). However, 
neurological and psychiatric control groups are inherently abnormal, 
and therefore attributing findings solely to the FND group can be chal-
lenging. Including two controls groups (one healthy and one neuro-
psychiatric control group) may be preferable for many study designs 
(Espay et al., 2018b, 2018c; Szaflarski et al., 2018); it may be particu-
larly useful when the choice of the neuropsychiatric control group en-
ables the subtraction out of effects related to conditions commonly 
co-occurring in FND (e.g., chronic migraine, generalized anxiety disor-
der, personality disorder, etc.), while the parallel use of healthy controls 
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contextualize findings as outside or inside the range of normal. While a 
transdiagnostic approach embracing the recruitment of mixed FND co-
horts is increasingly being adopted to aid the investigation of shared 
neural mechanisms across subpopulations (Perez et al., 2015), including 
two or more isolated FND subtypes (e.g., functional limb weakness vs. 
functional dystonia) may aid the identification of subtype-specific 
findings (Canu et al., 2020; Sojka et al., 2021; Tomic et al., 2018). 
Relatedly, initial machine learning neuroimaging studies investigating 
the utility of such approaches as adjunctive diagnostic tools used healthy 
controls (Vasta et al., 2018; Wegrzyk et al., 2018), but including 
conditions on the differential diagnosis for FND (e.g., epilepsy, primary 
dystonia) will further test the specificity of such methods. 
In terms of state (patients with active symptoms) vs. trait (patient- 
specific characteristics in those without current symptoms), within- 
group longitudinal designs can be informative. Some studies used pa-
tients as their own controls, with and without symptoms (Vuilleumier 
et al., 2001) or before and after treatment (Espay et al., 2019; Faul et al., 
2020). An advantage of within-subject designs are their enhanced sta-
tistical power. 
Table 1 
Examples of task-based neuroimaging studies in functional neurological disorder.  
Tasks Task Descriptions Construct(s) Interrogated FND Type FND Studies 
Motor-related Preparing and attempting to move limbs Motor preparation, performance, observation, control, 
and/or imagery 
FND-par Marshall et al., 1997 
Joystick paced movements FND-par Spence et al., 2000 
Preparing and attempting projected hand 
movements 
FND-par Burgmer et al., 2006 
Action choice based on visual stimuli FND-par Stone et al., 2007 
Judging laterality of visually presented 
rotated hands 
FND-par de Lange et al., 2007 
Go / No-Go task FND-par Cojan et al., 2009 
Imagination and execution of movements FND-par van Beilen et al., 2011 
Action selection task FND-movt Voon et al., 2011 
Metronome paced movements FND-dystonia Schrag et al., 2013 
Passive movements of hands FND-par Hassa et al., 2017 
Finger tapping task FND-dystonia Espay et al., 2018b 
Finger tapping task FND-tremor Espay et al., 2018c  
Affective and threat 
processing 
Facial emotion recognition Affective processing & control, traumatic memory 
processing, avoidance learning, and/or psychological 
stress response 
FND-movt Voon et al., 2010a  
Motor FND Aybek et al., 2015  
FND-par Hassa et al., 2017  
FND-dystonia Espay et al., 2018b  
FND-seiz Szaflarski et al., 2018  
FND-tremor Espay et al., 2018c  
FND-tremor Espay et al., 2019 
Viewing emotive images FND-dystonia Espay et al., 2018b  
FND-tremor Espay et al., 2018c  
FND-tremor Espay et al., 2019  
FND-movt Sojka et al., 2019 
Recall of trauma-themed events with 
varying relevance to symptom onset 
Motor FND Aybek et al., 2014b 
Affectively conditioned associative 
learning 
FND-mixed Morris et al., 2017 
Easy vs. hard math and positive vs. 
negative social feedback (Montreal Stress 
Imaging Task) 
FND-seiz Allendorfer et al., 2019  
FND-seiz (TBI) Balachandran et al., 2020 
Self-agency & motor 
awareness 
Functional vs. voluntary tremor task  FND-tremor Voon et al., 2010b  
Glove-based hand motion control FND-movt Nahab et al., 2017  
Libet Clock FND-mixed Baek et al., 2017 
Emotion-motor 
interaction 
Grip force measure while observing 
emotional images 
Limbic-motor interactions Motor FND Blakemore et al., 2016 
Passive movement while observing 
emotional faces 
FND-par Hassa et al., 2017 
Emotional Go / No-Go FND-movt Faul et al., 2020  
Somatosensory 
perception 
Vibro-tactile stimuli application Sensory processing FND-par Vuilleumier et al., 2001  
FND-sensory Ghaffar et al., 2006  
FND-sensory Burke et al., 2014 
Brush stimulation FND-sensory Mailis-Gagnon et al., 
2003 
Other paradigms Intense mechanical stimulation Pain processing FND-sensory Mailis-Gagnon et al., 
2003 
Virtual-reality rollercoaster stimulation Self-motion perception FND-3PD Riccelli et al., 2017   
FND-3PD Passamonti et al., 2018 
Visually-guided action judgement using 
perceptual conflict 
Metacognition & motor awareness Motor FND Bègue et al., 2018 
Note: task organization in this table aims to broadly group paradigms across studies based on similar constructs tested, however, the reader should note that there are 
important nuances to many of these tasks that should be carefully inspected by reading the original article. Abbreviations: FND, functional neurological disorder; FND- 
seiz, functional [psychogenic nonepileptic / dissociative] seizures; FND-dystonia, functional dystonia; FND-tremor, functional tremor; FND-mixed, FND with mixed 
symptoms; FND-par, functional limb weakness/paresis; FND-movt, functional movement disorder; motor FND includes both FND-movt and FND-par; FND-3PD, 
persistent postural perceptual dizziness; FND-sensory, FND with sensory symptoms; TBI, traumatic brain injury. 
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5. Task-based Neuroimaging 
Task-based functional MRI (fMRI) measuring blood-oxygen-level- 
dependent (BOLD) signal, and to a lesser extent nuclear imaging ap-
proaches (i.e., positron emission tomography (PET), single-photon 
emission computed tomography (SPECT)) has been used to interrogate 
neural activations in FND. Examples of experimental paradigms used to 
date are illustrated below and in Table 1. 
Initial studies explored motor execution/control circuits in patients 
with functional limb weakness while participants tried to move their 
paretic limb compared with their unaffected limb (Marshall et al., 
1997), or compared with subjects feigning limb paralysis (Spence et al., 
2000; Stone et al., 2007). Other early functional limb weakness case 
studies probed motor preparedness, motor observation and imagined 
movements (Burgmer et al., 2006; Cojan et al., 2009; de Lange et al., 
2007; Marshall et al., 1997; van Beilen et al., 2011). Basic motor per-
formance (e.g., finger tapping) tasks have also been used in FND-movt 
populations (Espay et al., 2018b, 2018c; Schrag et al., 2013). Recent 
studies have investigated the interplay between motor control and 
emotion processing using paradigms such as an emotional Go/No-Go 
(Faul et al., 2020; Hassa et al., 2017); in another study, participants 
were asked to maintain grip strength while viewing affectively-valenced 
images (Blakemore et al., 2016). 
Limbic and salience networks can be interrogated with affectively- 
valenced facial expression processing tasks, an approach commonly 
used in FND research (Aybek et al., 2015; Hassa et al., 2017; Voon et al., 
2010a). Other studies used affectively-valenced picture viewing tasks (e. 
g., the International Affective Picture System) to probe emotion pro-
cessing/regulation circuits in FND populations (Espay et al., 2018b, 
2018c; Sojka et al., 2019). Using a different approach, an affective 
memory response was explored by invoking traumatic memories with 
varying theorized relevance to patients’ functional neurological symp-
toms in the scanner (Aybek et al., 2014b; Kanaan et al., 2007). 
Cognitive-mediated stress responses in FND have also been investigated 
using easy vs. hard mathematical calculations and positive vs. negative 
social stressors from the Montreal Stress Imaging Task (Allendorfer 
et al., 2019; Balachandran et al., 2020). 
Another construct explored is impaired self-agency in patients with 
FND-movt perceiving their functional movements as involuntary (Bai-
zabal-Carvallo et al., 2019). One study compared brain activations 
during two conditions where the voluntary perception of tremor was 
different: in one condition patients could voluntarily trigger a tremor by 
moving their arm into a certain position and in the other condition pa-
tients displayed their functional tremor without any perceived voluntary 
control (Voon et al., 2010b). Other studies have interrogated self-agency 
using the Libet clock paradigm (Baek et al., 2017) and by manipulating 
visual feedback of a motor action with a cyber glove (Nahab et al., 
2017). 
Additional constructs probed in FND task-based neuroimaging 
research to date include avoidance learning (Morris et al., 2017), motor 
inhibition (Cojan et al., 2009), virtual-reality associated motion 
perception (Riccelli et al., 2017), meta-cognition (Bègue et al., 2018), 
symptom modeling with suggestion (Deeley, 2016), somatosensory 
processing(Burke et al., 2014; Ghaffar et al., 2006; Vuilleumier et al., 
2001) and nociception (Mailis-Gagnon et al., 2003). No functional 
neuroimaging studies to date have explicitly probed catastrophizing, 
interoception or predictive processing more broadly, which are addi-
tional constructs of theoretical relevance to the pathophysiology of FND 
(Drane et al., 2020; Edwards et al., 2012; Fobian et al., 2020; Koreki 
et al., 2020). Relationships between lateralized symptoms and hemi-
spheric brain activations also require additional inquiry, including the 
use of flipped and unflipped data analytic approaches (van Beilen et al., 
2011). 
For task-based neuroimaging, there are several relevant methodo-
logical considerations. Block designs favored in many early FND studies 
have superior statistical power but can yield confounds arising from 
stimulus order predictability (Friston et al., 1999). Event-related de-
signs, while lacking somewhat in statistical power, allow sorting of trial 
responses according to specific behavioral outcomes such as motor er-
rors or a subjective judgment of affectively-valenced stimuli (Chee et al., 
2003). Although task fMRI has good spatial resolution (compared to PET 
and SPECT), temporal resolution is limited by the hemodynamic 
response, which is a concern when studying sub-second range cognitive- 
affective-perceptual processes (Khanna et al., 2015). Task fMRI tech-
niques in-development utilizing fast, sub-second approaches may soon 
overcome these issues (Sahib et al., 2018). 
6. Resting State Networks 
RsfcMRI measures BOLD signal while an individual is awake but not 
engaged in any specified task. To analyze BOLD signal in the resting- 
state, some FND researchers have studied the temporal dynamics of 
the time series (e.g., amplitude of low frequency fluctuations (ALFF)) (Li 
et al., 2015a; Yang et al., 2020). However, rsfcMRI approaches inter-
rogating brain networks in FND cohorts are more popular (Chen et al., 
2020; Foroughi et al., 2020) (see Table 2). rsfcMRI analyses examine the 
dependency between the time series of different brain regions to 
compute a similarity measure between them. A common connectivity 
measure used in FND research is seed-based functional connectivity that 
characterizes relationships between a seed (region-of-interest (ROI)) 
and the rest of the brain. In FND studies, seed selection has been based 
on task fMRI activations within the same cohort (Allendorfer et al., 
2019; Baek et al., 2017; Szaflarski et al., 2018; van der Kruijs et al., 
2012), neuroanatomical atlases (e.g., automatic anatomic labeling) 
(Canu et al., 2020; Lee et al., 2018; Li et al., 2015b; Morris et al., 2017), 
voxel-based coordinates informed by meta-analyses (Canu et al., 2020; 
Maurer et al., 2016), or a priori hypotheses (Spagnolo et al., 2020). 
While seed-based connectivity is readily interpretable, this approach 
does not necessarily capture a complete picture of the global brain ar-
chitecture. To reduce the dimensionality of whole brain data into a set of 
networks, studies in FND have employed data-driven parcellations 
including independent component analysis (ICA) (Canu et al., 2020; van 
der Kruijs et al., 2014) and clustering (Monsa et al., 2018). To study 
intrinsic network architecture properties, graph theory rsfcMRI tech-
niques have been used, including characterizing network segregation 
and integration (Rubinov and Sporns, 2010). Here, nodes (ROIs) and the 
connectivity parameter (known as an edge or link) must be defined. 
Connectivity is represented by an adjacency matrix (either voxel × voxel 
or ROI × ROI) that examines the relationships across all pairs of regions. 
Several FND studies have applied graph theory rsfcMRI, using con-
nectome measurements including weighted-degree (centrality), clus-
tering coefficient, small worldness, and link-level metrics (Amiri et al., 
2021; Diez et al., 2020; Ding et al., 2013, 2014). For interpretability, 
nodes that are highly connected to other brain areas (indexed via cen-
trality) are termed “hubs”. A hybrid seed-based graph theory approach 
that allows for the characterization of information flow across brain 
networks, stepwise functional connectivity, has also been used in one 
study (Diez et al., 2019). Dynamic rsfcMRI (e.g., sliding window ap-
proaches) characterize the intrinsic variance of network connectivity 
across the duration of the scan (rather than averaging BOLD signal for 
the entire scan); one FND study has used this methodology to date 
(Marapin et al., 2020). Lastly, while the above techniques extract 
network properties and subsequently perform statistical analyses, ma-
chine learning can identify features with potential diagnostic utility; a 
linear Support Vector Machine classifier was used in an FND cohort to 
identify network features with predictive diagnostic potential (Khosla 
et al., 2019; Wegrzyk et al., 2018). 
Additionally, while the full range of rsfcMRI methodological con-
siderations is beyond the scope of this article, head motion is a note-
worthy issue given the presence of motor symptoms; as such, 
preprocessing and statistical analyses should explicitly address head 
motion artifacts (Power et al., 2015). Several studies have included head 
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motion parameters as nuisance variables, as well as performing spike- 
detection (scrubbing) to “de-noise” data (Allendorfer et al., 2019; Diez 
et al., 2020, 2019a; Lee et al., 2018; Maurer et al., 2016; Spagnolo et al., 
2020; Szaflarski et al., 2018). 
7. Grey Matter Characterization 
Given that brain structure–function relationships are closely 
coupled, a growing body of literature characterized grey matter in pa-
tients with FND. To date, these approaches include manual tracing 
(Atmaca et al., 2006, 2016), voxel-based morphometry (VBM) (Aybek 
et al., 2014a; Espay et al., 2018c; Kozlowska et al., 2017a; Labate et al., 
2012; Maurer et al., 2018; Perez et al., 2017a, 2017b, 2018b; Riederer 
et al., 2017) and surface-based methods (Labate et al., 2012; Nicholson 
et al., 2014; Nigro et al., 2019; Ospina et al., 2019; Perez et al., 2018a; 
Ristic et al., 2015; Tomic et al., 2018; Vasta et al., 2018; Williams et al., 
2018) (see Table 3). Manual tracing, historically considered the gold 
standard, requires a skilled neuroanatomist to hand trace ROIs. This is a 
time- and resource-intensive process, with variable intra- and inter- 
operator reliability (Morey et al., 2009). However, manual tracing can 
provide a good solution to quantifying volumes in relatively discrete 
subcortical structures. In FND, studies have used manual tracing to 
quantify basal ganglia, thalamic and pituitary volumes (Atmaca et al., 
2006, 2016). 
In FND research, manual tracing has been largely replaced by auto-
matic methods such as VBM and surface-based morphometry. VBM is a 
fully-automated process that statistically analyzes each T1 anatomical 
scan at the voxel-level. This procedure requires that images be trans-
formed to a common anatomical space to assure correspondence across 
subjects, generally using the Statistical Parametric Mapping (SPM) 
(Ashburner and Friston, 2000) or FMRIB Software Library (FSL) VBM 
analysis pipelines (Jenkinson et al., 2012). Other important VBM steps 
include tissue segmentation, where normalized images are separated 
into grey matter, white matter and cerebrospinal fluid components using 
tissue probability masks, and smoothing, where data is made more 
compatible with the Gaussian field model. Some processing steps can 
introduce variability in statistical analyses, such as co-registration and 
partial-volume effect concerns (Larvie and Fischl, 2016). Several studies 
in FND have employed VBM to perform whole-brain (Aybek et al., 
2014a; Espay et al., 2018c; Kozlowska et al., 2017a; Labate et al., 2012; 
Maurer et al., 2018; Perez et al., 2017b) or ROI-based analyses (Nich-
olson et al., 2014; Perez et al., 2017a, 2018b). Additionally, while 
surface-based analyses have been more widely used for cortical thick-
ness measurements, one FND study combined VBM and voxel-based 
cortical thickness analyses (Aybek et al., 2014a). 
Surface-based, semi-automated algorithms implemented in tools like 
FreeSurfer (http://surfer.nmr.mgh.harvard.edu/fswiki) enable the 
quantification of grey matter architecture based on reconstructed grey 
Table 2 
Resting-state fMRI approaches performed in functional neurological disorder to date.  
Technique Methodological Description Strengths & Weaknesses FND Studies 
Amplitude of Low Frequency 
Fluctuations (ALFF)/Fractional 
ALFF (fALFF) 
Frequency-domain analyses based on power 
spectrum reflecting spontaneous regional 
neural activity. 
ALFF has better reliability in grey matter than 
fALFF. ALFF is more sensitive to individual 
differences, while fALFF may be more prone to 
bias from physiological noise. 
Li et al., 2015a; Maurer et al., 2016; 
Spagnolo et al., 2020 
Seed-Based rsfcMRI Evaluates correlations between time series in a 
given seed (ROI) compared to other brain areas 
to identify spatially distinct networks. 
Readily interpretable. Findings are dependent 
in part on seed selection. Approaches to seed 
selection include using anatomical atlases, 
coordinates informed by the literature (e.g., 
meta-analysis) or task-based activations 
among other possibilities. 
Allendorfer et al., 2019; Baek et al., 2017; 
Canu et al., 2020; Lee et al., 2018; Li et al., 
2015a,b; Maurer et al., 2016; Morris et al., 
2017; Spagnolo et al., 2020; Szaflarski 
et al., 2018; van der Kruijs et al., 2012 
Data-Driven Component and 
Clustering Approaches 
Analyses aim to reduce the dimensionality of 
whole brain data into a smaller set of networks, 
using approaches such as independent 
component analyses (ICA) and clustering 
analysis. 
Techniques are model free and not dependent 
on seed selection. In ICA, user pre-specifies or 
estimates the number of components. Once 
voxels are grouped together, the user discerns 
which data sets reflect neural organization and 
which reflect physiological noise. 
van der Kruijs et al., 2014 Monsa et al., 
2018 Canu et al., 2020 
Graph Theory Network 
Applications 
Characterize the functional connectome using 
a correlation matrix and defining the nodes 
(ROIs) and connectivity strength 
measurements (links or edges). 
Allows for the study of both of specific 
networks (segregation) as well as interactions 
across networks (integration). Techniques to 
define nodes include use of anatomical atlases 
and voxel-based approaches. Procedures are 
computationally demanding and multiple 
comparison considerations are important. 
Clinical translation of certain graph theory 
network properties to brain networks can be 
challenging. 
Amiri et al., 2021; Diez et al., 2019, 2020, 
Ding et al., 2013, 2014 
Dynamic (Sliding Window) 
rsfcMRI 
Characterizes the intrinsic variance of network 
connectivity across the duration of the resting- 
state scan (rather than averaging BOLD signal 
for the entire scan) 
Allows for the quantification of fluctuations in 
resting-state connectivity across the duration 
of the scan. Window length selection is 
somewhat arbitrary and approach can be 
sensitive to outliers. 
Marapin et al., 2020 
Machine Learning Analyses aim to distinguish a given patient 
group from comparison cohorts. Predictions 
can also be applied to characterizing 
relationships between non-imaging measures 
of interest and individual differences. 
In unsupervised approaches, mathematical 
computations seek to disentangle explanatory 
variables in rich, unlabeled rsfcMRI data. 
Other approaches are supervised with greater 
user input regarding criteria for classification. 
For classifier-based analyses, the specificity 
and sensitivity of the findings can be 
calculated. Computations generally require 
large sample sizes and similar to graph theory, 
this approach is computationally demanding. 
Wegrzyk et al., 2018 
The Abbreviations: FND, functional neurological disorder; BOLD, blood-oxygen-level-dependent; rsfcMRI, resting-state functional connectivity magnetic resonance 
imaging; fMRI, functional magnetic resonance imaging; ROI, region of interest. 
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matter, white matter and pial surface boundaries (Fischl, 2012). Vertex 
measurements from these surfaces enable the calculation of several 
morphometric determinations, including cortical thickness, surface 
area, and curvature. Automated tracings using FreeSurfer also allow 
segmentation of subcortical structures, enabling volume measurements. 
While in vivo surface-based calculations have been validated against 
post-mortem measurements (Rosas et al., 2002), visual inspection of 
segmentation results is required to ensure that surface determinations 
were accurately demarcated. In the FND literature, whole-brain cortical 
surface analyses have been commonly employed (Labate et al., 2012; 
McSweeney et al., 2018; Nigro et al., 2019; Ospina et al., 2019; Perez 
et al., 2018a; Ristic et al., 2015; Tomic et al., 2018; Vasta et al., 2018; 
Williams et al., 2018), with cortical thickness measures extracted in all 
studies. Additionally, one study combined surface-based measurements 
with a random forest machine-learning algorithm to investigate struc-
tural MRI characteristics that distinguished patients with FND-seiz 
compared to healthy controls (Vasta et al., 2018). Other multivariate 
analyses such as source-based morphometry have yet to be used in pa-
tients with FND. 
Grey matter characterization using neuroimaging techniques also 
has general limitations that are important considerations, such as 
insufficient contrast in T1-weighted sequences to completely delineate 
deep grey matter structures (Pagnozzi et al., 2019). False positive rates 
may also be higher for volume and surface area calculations compared to 
cortical thickness measurements (Greve and Fischl, 2018). 
8. White Matter Characterization 
White matter characterization using diffusion-weighted imaging in 
FND is in its early stages. Diffusion-weighted imaging, commonly 
diffusion tensor imaging (DTI), quantifies the movement of water mol-
ecules along axons and allows for an in vivo characterization of a) the 
local microstructural white matter integrity, and b) the reconstruction of 
white matter connections using tractography (Jones et al., 2013). 
Tractography-based graph theory analyses may further elucidate struc-
tural brain networks (Rubinov and Sporns, 2010). 
Voxel-based approaches to characterize white matter in patients 
with FND rely on scalars derived from DTI, most commonly fractional 
anisotropy (FA, a measure of microstructural integrity) and mean 
diffusivity (MD). These have been investigated in FND cohorts using 
tract-based spatial statistics (TBSS, i.e. voxel-wise analysis of skeleton-
ized local diffusion measures) (Jungilligens et al., 2021; Lee et al., 2015; 
Sone et al., 2019; Tomic et al., 2018) and voxel-based analysis (Sojka 
et al., 2021). Alternatively, individual white matter tracts or a 
whole-brain connectome can be constructed using tractography. FND 
studies have applied both deterministic (Ding et al., 2013; Hernando 
et al., 2015; Li et al., 2015b) and probabilistic tractography (Diez et al., 
2021; Jungilligens et al., 2021; Sojka et al., 2021). Furthermore, three of 
the aforementioned studies (Diez et al., 2021; Ding et al., 2013; Sone 
et al., 2019) used graph theoretical analysis to study the structural 
connectome of patients with FND. One study employed network lesion 
mapping to identify the grey matter origins of white matter findings 
(Sojka et al., 2021). In addition to conventional diffusion-weighted 
imaging, high angular resolution diffusion imaging (HARDI), which 
can more accurately delineate crossing fibers, has been applied in a 
FND-seiz cohort; this study also used the neurite orientation dispersion 
and density indices (NODDI) toolbox to characterize neurite dispersion, 
density and isotropic-free water volume fraction (Goodman et al., 2020). 
See Table 4 for a description of white matter approaches published in 
FND to date. 
While diffusion-weighted imaging is a valuable tool, there are 
methodological considerations. Due to its reliance on detecting small 
displacements of water, DTI is susceptible to head motion artifacts 
(Yendiki et al., 2014). Furthermore, conventional DTI measures only one 
overall direction and degree of isotropy per voxel. In voxels containing 
crossing fibers, this leads to difficulties in estimating the underlying 
‘true’ diffusion directions contributing to the overall signal. Approaches 
such as HARDI may more reliably account for crossing fibers, but 
acquisition times are longer than conventional DTI (Schilling et al., 
2018). 
9. Other Imaging Approaches 
Besides functional/structural MRI and diffusion-weighted tech-
niques, other neuroimaging modalities used in FND research include 
nuclear medicine (i.e., PET and SPECT), magnetic resonance spectros-
copy (MRS) and near-infrared spectroscopy (NIRS). Nuclear medicine 
approaches have been applied to FND populations during both rest and 
task performance (Czarnecki et al., 2011; Galli et al., 2019; Marshall 
et al., 1997; Schrag et al., 2013; Song et al., 2014; Spence et al., 2000; 
Vuilleumier et al., 2001). Interictal and ictal SPECT, and interictal PET, 
have been used to differentiate FND-seiz and epileptic seizure cohorts 
(Baslet et al., 2021; Biraben et al., 1999; Neiman et al., 2009; Olver et al., 
2019; Varma et al., 1996). 
Table 3 
Grey matter characterization approaches performed in functional neurological disorder to date.  
Technique Methological Description Strengths & Weaknesses FND Studies 
Manual tracing Quantification of grey matter structures 
based on tracings by hand of the whole brain 
or regions-of-interest. 
Historically considered the gold standard as it 
provides accurate identification of neural 
structures, and is particularly useful for small 
subcortical and limbic structures. Time- and 
resource-demanding process not readily 
applicable to large datasets. 
Atmaca et al., 2006, 2016 
Voxel-based morphometry (VBM) Statistical comparison of grey-matter 
intensities for each voxel between 
participants. 
Fully automated process that can be applied to 
large datasets to quantify voxel-level grey 
matter density. Several processing steps may 
be prone to variability, including co- 
registration and partial-volume effect 
concerns. 
Aybek et al., 2014a; Espay et al., 2018c; 
Kozlowska et al., 2017a; Labate et al., 2012; 
Maurer et al., 2018; Perez et al., 2017a,b, 
2018b; Riederer et al., 2018 
Surface-based morphometry Reconstruction of the surfaces between grey 
matter, white matter and pial surface, 
allowing for the calculation of cortical 
metrics (thickness, surface area, curvature 
etc.) 
Semi-automated process that can be applied to 
large datasets, with in vivo measurements 
correlating well with post-mortem 
measurements. Provides a volume-based 
segmentation stream for subcortical structures. 
Pial and white matter boundaries benefit from 
visual inspection and some metrics may be 
difficult to interpret (e.g., curvature). 
Labate et al., 2012; McSweeney et al., 2018; 
Nicholson et al., 2014; Nigro et al., 2019; 
Ospina et al., 2019; Perez et al., 2018a; 
Ristic et al., 2015; Tomic et al., 2018; Vasta 
et al., 2018; Williams et al., 2018 
The Abbreviations: FND, functional neurological disorder. 
D.L. Perez et al.                                                                                                                                                                                                                                 
NeuroImage: Clinical 30 (2021) 102623
9
In terms of neurochemical studies, two MRS studies have been per-
formed in FND (Demartini et al., 2019; Simani et al., 2020). A NIRS 
study differentiated cardiogenic syncope from functional episodes dur-
ing a tilt-test examination (Claffey et al., 2020), as it confirmed a stable 
cerebral tissue saturation index. While beyond the scope of this article, 
electrophysiological approaches including quantitative electroenceph-
alography (EEG), spectral power, source localization, and event-related 
potentials have also been applied to FND (Barzegaran et al., 2015; 
Hallett, 2016a, 2016b; Kozlowska et al., 2017b, 2018; Meppelink et al., 
2017; van der Salm et al., 2012). Promising techniques not yet used to 
study the pathophysiology of FND include ligand-based nuclear medi-
cine techniques (including MRI-PET approaches), EEG-fMRI, and com-
bined transcranial modulation–fMRI studies. 
10. Individual Differences: Biomarkers of Symptom Severity, 
Illness Duration and Risk Factors for Developing FND 
There is a small but growing number of studies reporting on the 
neural correlates of symptom severity and illness duration as well as 
variables that might influence risk of developing FND, particularly 
adverse childhood experiences. Across structural and functional neuro-
imaging studies, indices of patient-reported symptom severity (e.g., 
FND-seiz frequency, disability from functional dizziness) and/or illness 
duration have been used as covariates of interest in within-group designs 
in several FND cohorts (Atmaca et al., 2016; Aybek et al., 2014a; Diez 
et al., 2019, 2021; Jungilligens et al., 2021; Kozlowska et al., 2017a; 
Labate et al., 2012; Lee et al., 2015; Li et al., 2015a,b; Maurer et al., 
2018; McSweeney et al., 2018; Nicholson et al., 2014; Perez et al., 
2017a; Riccelli et al., 2017). 
Data on brain – risk factor relationships in FND are relatively sparse, 
and mostly inferred from trauma history. Notably, several studies have 
investigated brain – trauma burden relationships using self-report 
measures (e.g., Childhood Trauma Questionnaire, Life Events Check-
list) in FND cohorts (Diez et al., 2020; Jungilligens et al., 2021; 
Kozlowska et al., 2017a; Maurer et al., 2016, 2018; Perez et al., 2017a; 
Spagnolo et al., 2020). The role of other biopsychosocial-informed risk 
factors such as dissociation, alexithymia, personality profiles, insecure 
attachment, and social behaviors have received minimal attention to 
date (Labate et al., 2012; Ospina et al., 2019; Passamonti et al., 2018; 
Perez et al., 2018a; Sojka et al., 2019; van der Kruijs et al., 2012, 2014; 
Williams et al., 2018). Furthermore, in some patients dissociation and 
alexithymia may represent intrinsic aspects of the same FND-related 
pathophysiology rather than risk factors per se. Sex-differences in the 
neurobiology of FND are also understudied (Maurer et al., 2018; Perez 
et al., 2017a; Williams et al., 2018). 
Given the clinical heterogeneity found in FND, potential biological 
subtypes (e.g., intermediate phenotypes and endophenotypes) may be 
important considerations. For example, individual differences in child-
hood abuse burden correlated with corticolimbic resting-state functional 
connectivity in FND cohorts (Diez et al., 2020; Maurer et al., 2016); this 
suggests that a subset of individuals with FND (particularly those with 
adult onset) could potentially be conceptualized as having a delayed 
trauma-related disorder. Furthermore, differences in single-nucleotide 
polymorphisms of the tryptophan hydroxylase 2 gene in the context of 
studying gene by environment interactions have preliminarily identified 
biologically distinct FND subgroups (Spagnolo et al., 2020). 
11. Imaging Predictive Biomarkers and Mechanisms of 
Treatment Response 
With interest in developing FND treatments, recognized heteroge-
neity in outcomes among patients, and challenges in defining optimal 
clinical trial outcome measures (Nicholson et al., 2020; Pick et al., 
2020), neuroimaging may help elucidate neural mechanisms and 
Table 4 
White matter characterization approaches performed in functional neurological disorder to date.  
Technique Methological Description Strengths & Weaknesses FND Studies 
Tract-based spatial statistics 
(TBSS) 
Voxel-wise analysis of diffusion indices to quantify 
the local strengths of axonal directionality within 
white matter tracts. 
Assesses white matter microstructural integrity, 
independent of local fiber orientation. Results are 
difficult to interpret in areas of crossing fibers, subject to 
partial volume effects in thin tracts and prone to head 
movement effects. 
Jungilligens et al., 2021; Lee 
et al., 2015; Sone et al., 
2019; Tomic et al., 2018 
Voxel-based analysis (VBA) Voxel-wise approach to quantify diffusion indices 
throughout the subcortical white matter. 
White matter assessments are not limited to a 
skeletonized map. If used in isolation, some difficulty 
relating findings to known fiber bundles. Accuracy of 
registration algorithms important. 
Sojka et al., 2021 
Tractography (deterministic) Reconstruction of white matter connections based 
on a preset (deterministic) direction at each voxel. 
More specific results than with probabilistic 
tractography, higher efficiency. Lower re-test reliability 
than probabilistic models, susceptible to noise, unable to 
account for inherent uncertainty in fiber orientation 
estimates. 
Ding et al., 2013; Hernando 
et al., 2015; Li et al., 2015b 
Tractography (probabilistic) Reconstruction of white matter tracts based on a 
stochastic spatial distribution estimates of fiber 
orientation. 
Shows greater reproducibility than deterministic 
models, and accounts for the inherent uncertainty in 
fiber orientation estimates. Less specific than 
deterministic models, with greater spatial dispersion of 
reconstructed streamline (may lead to more false- 
positive connections). 
Diez et al., 2021; 
Jungilligens et al., 2021; 
Sojka et al., 2021 
Graph theory-based Characterizes the structural connectome using 
nodes (cortical or subcortical regions-of-interest) 
and connectivity measurements (edges) derived 
from tractography. 
Macroscopic representation of structural connectome, 
quantifying the relative structural connectivity between 
cortical regions. Results dependent on node 
segmentation, requiring assumptions to characterize 
white matter. 
Diez et al., 2021; Ding et al., 
2013; Sone et al., 2019 
High angular resolution diffusion 
imaging (HARDI) 
Measures diffusion signal along more gradient 
directions than conventional diffusion tensor 
imaging (DTI). 
Can characterize both tensor metrics (e.g., fractional 
anisotropy) and tractography. Provides the orientation 
directions of multiple tracts found within a given voxel. 
Acquisition times are longer than traditional DTI 
sequences. 
Goodman et al., 2020 
The Abbreviations: FND, functional neurological disorder. 
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predictors of treatment response. Notably, neural circuit profiles pre-
dicting treatment response may or may not overlap with pathophysio-
logical mechanisms. 
Three studies examined functional activations and/or connectivity 
changes following treatment interventions (Espay et al., 2019; Faul 
et al., 2020; Vuilleumier et al., 2001). In one study, 15 patients with 
functional tremor underwent 12-weeks of CBT, as well as pre- and post- 
treatment participation in three tasks obtained during a single fMRI scan 
session: finger tapping, basic emotion processing (affectively-valenced 
face viewing) and intense emotion processing (International Affective 
Picture System images) (Espay et al., 2019). Here, relationships between 
baseline depression scores and post vs. pre-treatment activation patterns 
were investigated. Another fMRI study performed in 14 patients with 
FND-movt measured baseline and post-treatment activations using an 
emotional Go/No-Go task in the context of participating in a 5-day 
multidisciplinary motor retraining treatment program (Faul et al., 
2020). This study adjusted for depression and anxiety scores, and also 
investigated how baseline fMRI profiles related to treatment response. A 
SPECT study conducted in 7 patients with functional sensorimotor def-
icits probed blood flow patterns while symptomatic and 2–4 months 
later once symptoms resolved (treated with supportive psychotherapy 
and physiotherapy) (Vuilleumier et al., 2001). Additionally, two studies 
in 22 outpatients with mixed FND investigated how baseline resting- 
state functional connectivity (Diez et al., 2019) and grey matter (Perez 
et al., 2018b) profiles related to prospectively collected 6-month clinical 
outcomes following individualized treatments (e.g., CBT, physical 
therapy); baseline depression and anxiety scores were used to contex-
tualize findings. No prospective studies have evaluated relationships 
between white matter profiles and treatment outcomes. Real-time fMRI 
neurofeedback is another potential treatment to investigate in future 
FND research (Sukhodolsky et al., 2020). 
12. Research Agenda 
To summarize, FND neuroimaging research has grown over the past 
20 years but continues to lag behind other prevalent neuropsychiatric 
disorders. Emerging themes include: i) brain dysfunctions in FND are 
distinct from feigning; ii) the pathophysiology of FND implicates mul-
tiple brain networks across functional and structural neuroimaging 
studies (e.g., abnormal salience/limbic-motor control and rTPJ- 
sensorimotor network interactions in fMRI studies); iii) linking neural 
mechanisms to etiological factors in FND is still in its early stages, as are 
biomarker studies of treatment response and prognosis. Task and 
resting-state fMRI have been the most widely used modalities to date, 
with few attempts to consider multimodal data. Replication has also 
been limited. Furthermore, while researchers have rapidly adopted 
“rule-in” examination signs and semiological features as core compo-
nents of FND inclusion criteria, challenges remain regarding how (and 
if) to disentangle FND-related neural circuit profiles from other co- 
occurring mental and physical health symptoms. Likewise, questions 
regarding whether observed neuroimaging findings are disorder- 
specific, compensatory or linked to risk factors and confounds among 
other possibilities remain unanswered (Bègue et al., 2019). 
To advance FND neuroimaging research over the next decade, we 
recommend the following research agenda. Note, this neuroimaging- 
focused research agenda is partially informed by recently published 
pathophysiology-focused research agenda formulations (Drane et al., 
2020; Pick et al., 2019).  
• FND cohorts in neuroimaging studies require more detailed 
categorical and dimensional characterization across neurolog-
ical, medical and psychiatric/psychological domains: while 
emphasis on positive signs should remain a key inclusion criterion, 
future research should make concerted efforts to describe and 
quantify the range of functional neurological symptoms and other 
bodily symptoms experienced by individuals - most notably but not 
limited to pain, fatigue, and cognitive complaints (Maggio et al., 
2020; Nicholson et al., 2020). Additional work is also needed to 
operationalize and further validate rule-in signs for FND. Regarding 
FND phenotypes, the majority of studies to date focused on a single 
subtype (e.g., FND-seiz), while others further narrowed inclusion 
criteria to specific phenotypes within overarching categories (e.g., 
functional dystonia). While these efforts remain important, many 
patients with FND have mixed symptoms. Thus, greater clarity 
regarding the range of functional neurological symptoms present is 
needed in research cohorts; ongoing efforts by the FND Society to 
better operationalize FND diagnostic criteria will also aid cohort 
characterization. Similarly, consensus self-report and other mea-
surements assessing additional distressing bodily symptoms if widely 
adopted would advance this effort and aid future data aggregation 
(see below) (Pick et al., 2020). The presence of functional somatic 
disorders (e.g., fibromyalgia) and other neurological conditions (e.g., 
traumatic brain injury) should also be documented. Similarly, life-
time psychiatric symptomatology should be delineated using struc-
tured psychiatric interviews as well as dimensional 
psychopathological measurements; indices of adverse life experi-
ences should be assessed across the lifespan. Medication use with 
known central nervous system effects should also be consistently 
detailed. Of note, caution should be taken to not overly emphasize 
the recruitment of “pure” forms of FND (those without neuropsy-
chiatric comorbidities) – in part because the generalizability of such 
findings may be questionable. Furthermore, while we are recom-
mending more robust cohort characterizations, we are not neces-
sarily advocating for exhaustive assessments and recognize that 
investigators need to make tradeoffs depending on their study de-
signs and research questions.  
• While healthy controls remain important, patient controls 
across neurological, psychiatric and medical diagnoses are 
needed to help delineate the specificity of observed FND find-
ings. Such patient controls could include individuals with chronic 
pain disorders, migraine, fibromyalgia, mild traumatic brain injury, 
major depression, generalized anxiety disorder, panic disorder, 
PTSD, dissociative disorders or mixed mood/anxiety psychiatric 
controls among other possibilities. Notably, some of these patient 
controls may have an overlapping pathophysiology with FND, ob-
servations that will nonetheless clarify disease mechanisms. Addi-
tionally, controls with similar symptoms driven by likely distinct 
neural mechanisms offer the opportunity to identify diagnostic bio-
markers of FND; for example, comparing FND-seiz to epileptic sei-
zures and comparing FND-movt to neurological disorders causing 
similar symptoms (e.g., primary dystonia). Lastly, it is beneficial to 
characterize healthy controls with the same measurements as those 
applied to patient groups.  
• Study designs should complement between-group approaches 
with relevant stratified between-group and within-group ana-
lyses. Given that between-group (FND vs. controls) analyses are 
limited by the heterogeneity inherent to FND, stratified between- 
group analyses (FND-acute symptoms vs. FND-chronic symptoms; 
FND-prepubertal onset vs. FND-postpubertal onset) and within- 
group analyses provide important complementary information.  
• Longitudinal studies (naturalistic and pre/post treatment) are 
needed to investigate state vs. trait markers of FND patho-
physiology, as well as to identify prognostic biomarkers and 
neural mechanisms of treatment response. For example, while 
initial efforts have investigated structural and functional biomarkers 
of symptom severity cross-sectionally, it remains unclear how 
‘responsive’ structural and functional brain profiles are to symptom 
fluctuations over time. Longitudinal studies may also help disen-
tangle the importance of developmental trajectories and stress- 
diathesis model components in the pathophysiology of FND (Key-
nejad et al., 2019; Kozlowska, 2017). 
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• Within-group designs investigating neural circuit profiles 
associated with symptom severity and illness duration may be 
particularly informative in elucidating the pathophysiology of 
FND. As noted earlier, within-group designs can help account for co- 
occurring neuropsychiatric symptoms and improve statistical power; 
however, given that symptom severity and illness duration can also 
covary with other neuropsychiatric symptoms, secondary analyses 
should be performed with depression and anxiety scores (or similarly 
relevant factors) as covariates of noninterest.  
• In addition to mapping symptoms and relevant psychological 
constructs (e.g., agency, attentional biases, expectation/infer-
ence, alexithymia, dissociation, interoception, conversion, 
catastrophizing etc.) to neural circuit profiles, relationships 
between brain areas and other biological markers (neuroendo-
crine (e.g., stress and sex hormones), autonomic (e.g., heart rate 
variability and electrodermal skin responses), neuro-
inflammatory, genetic and epigenetic factors) should be inves-
tigated. Integrating a range of psychologically and biologically- 
relevant factors will help refine the understanding of links between 
what is observed in the brain and other bodily systems, as well as to 
overcome the dualism of separately studying psychological and 
neurobiological factors. Such multi-level measurement efforts will 
also help mitigate potential interpretation biases. Nonetheless, it is 
also important to note that while complex psychological functions 
can undoubtedly be further understood through neuroscience (Kan-
del, 2013), neuroimaging techniques – in their present form – may 
not be able to fully delineate some relevant processes such as free 
will(Hallett, 2016). Furthermore, composite biomarkers that include 
a range of psychobiologically-relevant variables may potentially 
exhibit greater explanatory power than a single measurement.  
• Multimodal (combined MRI, fMRI, DTI, EEG, and/or PET etc.) 
neuroimaging studies are encouraged to contextualize intrinsic 
structural and functional architectural profiles with task- 
related activation profiles. This is analogous to collecting data 
from a resting echocardiography and exercise stress test to obtain a 
more complete picture of cardiac functioning. In vivo neurochemical 
(MRS) and nuclear medicine-based neurotransmitter binding studies 
would likely also add insights into the pathophysiology of FND. 
Similarly, EEG-fMRI studies can provide improved temporal resolu-
tion, while fMRI-TMS studies can interrogate discrete brain circuits 
to provide causal information.  
• Understanding how FND mechanisms and etiological factors 
relate to one another is important. This should include efforts to 
contextualize roles for potential sex differences, developmental tra-
jectories, stress coping, resilience, attachment, alexithymia and 
epigenetic / genetic factors. Contextualizing relationships across risk 
factors, including delineating moderators is another noteworthy 
research area.  
• Larger sample sizes are needed to comprehensively perform 
secondary and post-hoc analyses aimed at adjusting for poten-
tial confounding variables, as well as to assist in ensuring that 
findings are robust and replicable. The future inclusion of test and 
replication cohorts in the same study would substantially increase 
the impact and clarity of neuroimaging findings.  
• To robustly address many of the above considerations, FND 
researchers should establish large-scale international data 
sharing initiatives. One high impact consideration is to join the 
Enhancing NeuroImaging Genetics through Meta-Analysis 
(ENGIMA) Consortium, an international effort by leaders world-
wide to bring together clinical neuroscience researchers to under-
stand pathological brain structure and function relationships, using 
MRI, DTI, fMRI & genetic data across patient populations (Thompson 
et al., 2020). ENIGMA’s ethos is that the best return on research 
investments will come from combining data to achieve large samples 
necessary to detect modest imaging/gene effect sizes that we now 
know are the rule rather the exception for complex traits. A 
particularly relevant consideration that we are actively exploring is 
to have FND researchers establish the FND working sub-group as part 
of the ENIGMA-Dissociation Working Group (Reinders, 2020). 
Dissociative symptoms are common in FND and its frequently co- 
occurring psychiatric conditions including PTSD, somatic symptom 
disorders, borderline personality disorder, anxiety disorders, and 
depersonalization/derealization disorder (Lyssenko et al., 2018). 
The ENIGMA-Dissociation Working Group is set up as an umbrella 
where individual subgroups investigate biomarkers of separate dis-
orders involving dissociative symptoms. The amalgamation of the 
within disorder specific dissociation biomarkers from these separate 
segments will ultimately inform the study of biomarkers for patho-
logical dissociation across disorders (Roydeva and Reinders, 2021). 
Additionally, disorder specific neural mechanisms could be investi-
gated by performing large-scale between-group comparisons across 
FND and its co-occurring psychiatric conditions. Participation in the 
ENIGMA Consortium would also allow access to neuroimaging data 
across a range of other relevant disorders (e.g. traumatic brain 
injury) (Dennis et al., 2020). 
13. Conclusions 
Neuroimaging research in FND has steadily matured alongside sub-
stantial progress made in the diagnosis and treatment of this population. 
This article provides readers with an overview of the state of neuro-
imaging research in FND, emphasizing conceptual and methodological 
considerations. A research agenda to promote high impact 
neuroimaging-focused research questions is also outlined. Given 
complexity inherent to the pathophysiology of FND, there is an urgent 
need for large-scale collaborations to more definitely answer key 
mechanistic questions regarding FND. Advancing the pathophysiology 
of FND, in part through multimodal neuroimaging approaches, has 
important ramifications not only for FND but also for a more holistic 
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